• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯成年人群临床化学分析物参考区间的建立:作为国际临床化学和检验医学联合会(IFCC)全球参考值研究的一部分开展的一项研究

Establishment of reference intervals of clinical chemistry analytes for the adult population in Saudi Arabia: a study conducted as a part of the IFCC global study on reference values.

作者信息

Borai Anwar, Ichihara Kiyoshi, Al Masaud Abdulaziz, Tamimi Waleed, Bahijri Suhad, Armbuster David, Bawazeer Ali, Nawajha Mustafa, Otaibi Nawaf, Khalil Haitham, Kawano Reo, Kaddam Ibrahim, Abdelaal Mohamed

出版信息

Clin Chem Lab Med. 2016 May;54(5):843-55. doi: 10.1515/cclm-2015-0490.

DOI:10.1515/cclm-2015-0490
PMID:26527074
Abstract

BACKGROUND

This study is a part of the IFCC-global study to derive reference intervals (RIs) for 28 chemistry analytes in Saudis.

METHOD

Healthy individuals (n=826) aged ≥18 years were recruited using the global study protocol. All specimens were measured using an Architect analyzer. RIs were derived by both parametric and non-parametric methods for comparative purpose. The need for secondary exclusion of reference values based on latent abnormal values exclusion (LAVE) method was examined. The magnitude of variation attributable to gender, ages and regions was calculated by the standard deviation ratio (SDR). Sources of variations: age, BMI, physical exercise and smoking levels were investigated by using the multiple regression analysis.

RESULTS

SDRs for gender, age and regional differences were significant for 14, 8 and 2 analytes, respectively. BMI-related changes in test results were noted conspicuously for CRP. For some metabolic related parameters the ranges of RIs by non-parametric method were wider than by the parametric method and RIs derived using the LAVE method were significantly different than those without it. RIs were derived with and without gender partition (BMI, drugs and supplements were considered).

CONCLUSIONS

RIs applicable to Saudis were established for the majority of chemistry analytes, whereas gender, regional and age RI partitioning was required for some analytes. The elevated upper limits of metabolic analytes reflects the existence of high prevalence of metabolic syndrome in Saudi population.

摘要

背景

本研究是国际临床化学和检验医学联合会(IFCC)全球研究的一部分,旨在得出沙特人群28种化学分析物的参考区间(RI)。

方法

按照全球研究方案招募年龄≥18岁的健康个体(n = 826)。所有标本均使用Architect分析仪进行检测。为进行比较,采用参数法和非参数法得出参考区间。研究了基于潜在异常值排除(LAVE)法二次排除参考值的必要性。通过标准差比(SDR)计算性别、年龄和地区导致的变异程度。采用多元回归分析研究变异来源:年龄、体重指数(BMI)、体育锻炼和吸烟水平。

结果

性别、年龄和地区差异的SDR分别对14种、8种和2种分析物具有显著意义。CRP的检测结果与BMI相关的变化显著。对于一些代谢相关参数,非参数法得出的参考区间范围比参数法更宽,且采用LAVE法得出的参考区间与未采用该法的结果显著不同。在考虑(BMI、药物和补充剂)有无性别划分的情况下得出参考区间。

结论

已为大多数化学分析物建立了适用于沙特人群的参考区间,而部分分析物需要按性别、地区和年龄划分参考区间。代谢分析物上限升高反映出沙特人群中代谢综合征的高患病率。

相似文献

1
Establishment of reference intervals of clinical chemistry analytes for the adult population in Saudi Arabia: a study conducted as a part of the IFCC global study on reference values.沙特阿拉伯成年人群临床化学分析物参考区间的建立:作为国际临床化学和检验医学联合会(IFCC)全球参考值研究的一部分开展的一项研究
Clin Chem Lab Med. 2016 May;54(5):843-55. doi: 10.1515/cclm-2015-0490.
2
Establishment of reference intervals for immunoassay analytes of adult population in Saudi Arabia.沙特阿拉伯成年人免疫分析物参考区间的建立。
Clin Chem Lab Med. 2020 Jul 28;58(8):1302-1313. doi: 10.1515/cclm-2019-1049.
3
Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults.推导健康加纳成年人临床化学分析物的性别和年龄特异性参考区间。
Clin Chem Lab Med. 2022 Jul 4;60(9):1426-1439. doi: 10.1515/cclm-2022-0293. Print 2022 Aug 26.
4
Establishing reference intervals for major biochemical analytes for the Russian population: a research conducted as a part of the IFCC global study on reference values.建立俄罗斯人群主要生化分析物的参考区间:作为 IFCC 全球参考值研究的一部分进行的研究。
Clin Biochem. 2020 Jul;81:47-58. doi: 10.1016/j.clinbiochem.2020.04.001. Epub 2020 Apr 9.
5
Establishment of reference intervals for hematological parameters of adult population in the western region of Saudi Arabia.沙特阿拉伯西部地区成年人群血液学参数参考区间的建立。
PLoS One. 2023 Feb 8;18(2):e0281494. doi: 10.1371/journal.pone.0281494. eCollection 2023.
6
Reference intervals for 33 biochemical analytes in healthy Indian population: C-RIDL IFCC initiative.健康印度人群 33 种生物化学分析物的参考区间:C-RIDL IFCC 倡议。
Clin Chem Lab Med. 2018 Nov 27;56(12):2093-2103. doi: 10.1515/cclm-2018-0152.
7
Determination of reference intervals for common chemistry and immunoassay tests for Kenyan adults based on an internationally harmonized protocol and up-to-date statistical methods.基于国际协调方案和最新统计方法,确定肯尼亚成年人常见化学和免疫测定检验的参考区间。
PLoS One. 2020 Jul 9;15(7):e0235234. doi: 10.1371/journal.pone.0235234. eCollection 2020.
8
Establishment of reference intervals of clinical chemistry analytes for the adult population in Egypt.建立埃及成年人临床化学分析物的参考区间。
PLoS One. 2021 Mar 19;16(3):e0236772. doi: 10.1371/journal.pone.0236772. eCollection 2021.
9
Establishment of reference interval for hemoglobin A1C and other hemoglobin subfractions for healthy Saudi adults.建立健康沙特成年人的血红蛋白 A1C 和其他血红蛋白亚组分的参考区间。
PLoS One. 2024 Mar 25;19(3):e0300028. doi: 10.1371/journal.pone.0300028. eCollection 2024.
10
A multicenter nationwide reference intervals study for common biochemical analytes in Turkey using Abbott analyzers.一项使用雅培分析仪在土耳其进行的多中心全国性参考区间研究,用于常见生化分析物。
Clin Chem Lab Med. 2014 Dec;52(12):1823-33. doi: 10.1515/cclm-2014-0228.

引用本文的文献

1
Association Between Uric Acid to HDL-C Ratio and Liver Transaminase Abnormalities: Insights from a Large-Scale General Population Study.尿酸与高密度脂蛋白胆固醇比值和肝转氨酶异常之间的关联:来自大规模普通人群研究的见解
Medicina (Kaunas). 2025 Aug 5;61(8):1417. doi: 10.3390/medicina61081417.
2
What Are the Normal Serum Creatine Kinase Values for Skeletal Muscle? A Worldwide Systematic Review.骨骼肌的正常血清肌酸激酶值是多少?一项全球系统性综述。
Eur J Neurol. 2025 Jun;32(6):e70240. doi: 10.1111/ene.70240.
3
Determination of reference intervals for common liver function tests among healthy adults.
健康成年人常见肝功能检查参考区间的确定。
Sci Rep. 2025 Apr 15;15(1):12896. doi: 10.1038/s41598-025-97545-8.
4
Association of GGT and hs-CRP with hypertension across different glycemic states in Saudi adults: A cross-sectional study.沙特成年人不同血糖状态下谷氨酰转肽酶和超敏C反应蛋白与高血压的关联:一项横断面研究
Heliyon. 2025 Feb 20;11(4):e42880. doi: 10.1016/j.heliyon.2025.e42880. eCollection 2025 Feb 28.
5
A Nationwide Nepalese Study to Establish Reference Intervals for Major Biochemical Analytes with Elucidation of Nepalese Features of Reference Values.一项在尼泊尔开展的全国性研究,旨在建立主要生化分析物的参考区间,并阐明参考值的尼泊尔特征。
Indian J Clin Biochem. 2024 Jul;39(3):1-12. doi: 10.1007/s12291-023-01123-6. Epub 2023 May 4.
6
Establishment of reference interval for hemoglobin A1C and other hemoglobin subfractions for healthy Saudi adults.建立健康沙特成年人的血红蛋白 A1C 和其他血红蛋白亚组分的参考区间。
PLoS One. 2024 Mar 25;19(3):e0300028. doi: 10.1371/journal.pone.0300028. eCollection 2024.
7
Establishment of Reference Intervals for Renal Function Clinical Chemistry Parameters in an Indonesian Tertiary Hospital.印度尼西亚某三级医院临床化学肾功能参数参考区间的建立。
Arch Razi Inst. 2023 Jun 30;78(3):955-961. doi: 10.22092/ARI.2022.360017.2530. eCollection 2023 Jun.
8
Variation in normative values of major clinical biochemistry analytes in healthy reproductive-age women in India: A subset of data from a National Indian Council of Medical Research-Polycystic Ovary Syndrome task force study.印度健康育龄期女性主要临床生物化学分析物参考值的变化:印度医学研究理事会多囊卵巢综合征工作组研究的部分数据。
Indian J Pharmacol. 2023 Mar-Apr;55(2):76-88. doi: 10.4103/ijp.ijp_694_22.
9
Establishment of reference intervals for hematological parameters of adult population in the western region of Saudi Arabia.沙特阿拉伯西部地区成年人群血液学参数参考区间的建立。
PLoS One. 2023 Feb 8;18(2):e0281494. doi: 10.1371/journal.pone.0281494. eCollection 2023.
10
Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia.探索沙特阿拉伯2型糖尿病患者中非酒精性脂肪性肝病(NAFLD)诊断中现有标志物和指标的有效性。
Diseases. 2023 Jan 15;11(1):10. doi: 10.3390/diseases11010010.